GlassScriptPhysician profile
Ammar A Al Obaidi
NPI 1437643269
$4,715.19
in general payments reported to CMS, 2019-2025
53 companies · $3,248 in 2025
The $3,248 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $125 · 2024: $1,218 · 2025: $3,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,653 · Consulting Fee: $780 · Education: $33.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,653.03 |
| Consulting Fee | $780.00 |
| Education | $33.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Geron Corporation | $810.73 | 2025 | Rytelo |
| Astrazeneca Pharmaceuticals LP | $294.31 | 2024-2025 | Imfinzi, Enhertu |
| Pfizer INC. | $285.35 | 2024-2025 | |
| Abbvie INC. | $255.59 | 2024-2025 | |
| Celgene Corporation | $201.54 | 2024-2025 | Breyanzi, Reblozyl, Opdualag |
| Stemline Therapeutics INC. | $195.16 | 2024-2025 | Orserdu, Elzonris |
| Merck Sharp & Dohme LLC | $133.61 | 2024-2025 | Keytruda, Welireg, Lynparza |
| Incyte Corporation | $124.97 | 2020 | |
| Viiv Healthcare Company | $124.18 | 2019 | |
| Janssen Biotech, INC. | $122.76 | 2024-2025 | Rybrevant, Talvey, Darzalex |
| Daiichi Sankyo INC. | $117.34 | 2024-2025 | Enhertu |
| Adaptive Biotechnologies Corporation | $108.85 | 2025 | Clonoseq |
| Regeneron Healthcare Solutions, INC. | $104.55 | 2024-2025 | Lynozyfic, Libtayo |
| Jazz Pharmaceuticals INC. | $102.32 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $89.22 | 2024-2025 | Opdivo |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $81.62 | 2024-2025 | Xalkori, Mektovi, Braftovi |
| Novartis Pharmaceuticals Corporation | $78.67 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.96 | 2025 | |
| Tersera Therapeutics LLC | $70.88 | 2024-2025 | Quzyttir, Zoladex |
| Glaxosmithkline, LLC. | $70.59 | 2024-2025 | Jemperli, Zejula, Ojjaara |
| Immunocore Limited | $69.37 | 2025 | Kimmtrak |
| Astellas Pharma US INC | $67.94 | 2024-2025 | Vyloy, Padcev |
| Genentech USA, INC. | $67.33 | 2024-2025 | Tecentriq, Tecentriq Hybreza, Polivy |
| Sobi, INC | $66.20 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $63.58 | 2024-2025 | Onivyde |
| Exelixis INC. | $58.49 | 2024-2025 | Cabometyx |
| Nxstage Medical, INC. | $57.66 | 2024 | |
| Aveo Pharmaceuticals, INC. | $52.22 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.53 | 2025 | Iclusig, Ninlaro |
| Bayer Healthcare Pharmaceuticals INC. | $51.23 | 2024-2025 | |
| Springworks Therapeutics, INC. | $48.54 | 2024-2025 | Ogsiveo |
| Amneal Pharmaceuticals LLC | $46.22 | 2025 | Alymsys, Pemrydi Rtu |
| Servier Pharmaceuticals LLC | $44.18 | 2024-2025 | |
| Avyxa Pharma, LLC | $41.15 | 2025 | |
| Legend Biotech USA INC. | $40.90 | 2025 | Carvykti |
| Blue Earth Diagnostics | $40.75 | 2024-2025 | Posluma |
| Genmab U.S., INC. | $38.17 | 2025 | Epkinly, Tivdak |
| Novocure INC. | $37.98 | 2024-2025 | Optune Lua (Novottf-200t) |
| Iovance Biotherapeutics, INC. | $34.95 | 2025 | Amtagvi |
| Eisai INC. | $31.44 | 2024 | |
| Blueprint Medicines Corporation | $30.26 | 2025 | Ayvakit |
| Mirati Therapeutics, INC. | $23.40 | 2024 | Krazati |
| Acrotech Biopharma INC. | $22.95 | 2024 | Beleodaq |
| Octapharma USA, INC. | $21.11 | 2025 | Octagam Immune Globulin (Human) |
| Apellis Pharmaceuticals, INC. | $20.62 | 2024 | Empaveli |
| Gilead Sciences, INC. | $19.81 | 2025 | Trodelvy |
| Pharmaessentia USA Corporation | $19.67 | 2024 | Besremi |
| Syndax Pharmaceuticals, INC. | $18.36 | 2025 | |
| Genzyme Corporation | $18.36 | 2025 | |
| Sun Pharmaceutical Industries INC. | $18.03 | 2025 | |
| Sumitomo Pharma America, INC. | $16.42 | 2025 | Orgovyx |
| Lilly USA, LLC | $16.20 | 2024 | Verzenio |
| Accord Healthcare, INC. | $14.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammar Al Obaidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.